… with dollars pouring into Chinese biotech assets, responding to a regulatory … curb burdensome regulations to accelerate drug development. Speeding clinical trials must … .  Furthermore, competition should diversify drug-approval pathways.  The current system …

… drug, TGN1412. This monoclonal antibody (mAb), discovered and developed by defunct biotech … clinical research, the agency encourages drug companies to use alternatives, such … begin immediately for investigational new drug applications where inclusion of these …

… Security Commission on Emerging Biotechnology recommends that the government dedicate … receptor for central nervous system drug delivery. 4. Sun Pharma … RemeGen lays out gMG drug’s China data with plans … awaiting FDA call on HAE drug, sells Japanese rights to …

… has always been precision. Antibody-drug conjugates (ADCs) offer a … selective antibody with a powerful drug payload, ADCs are redefining … ranges from small start-up biotech’s to pharma. She’ … the growing number of ADC drug candidates in development, strategic …

… to accelerate precision medicine and drug discovery. With a focus on … comprehensive capability empowers pharmaceutical companies, biotech firms, and academic institutions to …

… default approach, including by encouraging drugmakers to adopt other methods, like … alternative approaches with Investigational New Drug applications, which are used to … standards for the pharmaceutical and biotechnology industries.  The agency has been …

… , a subsidiary of the largest biotech company Amgen. This is reported … for the supply of certain drugs. We are talking about the …

The drugmaker's shares rallied after the release of its strong annual report, up by a cumulative 18% over the next three trading days Key Takeaways: Akeso's drug sales rose 25% last year to just above 2 billion yuan, setting a new high for the …

… successfully bringing in companies from biotech, medtech, and healthcare … Report showed that Swiss biotech startups received around 739 … million) in venture capital, biotechs in the region received around … impressive. The many new drugs that are in development …

… ) – across which Padeliporfin, a photosensitizing drug, is administered intravenously and VTP … of response.  About ImPact Biotech ImPact Biotech is an advanced clinical-stage … (VTP) therapy, a minimally invasive drug-device combination for selective ablation …